1-19 of 19
Authors: Bas Wijnhoven
Journal Article
249. OVERALL SURVIVAL OF PATIENTS WITH ESOPHAGEAL CANCER TREATED WITH DEFINITIVE CHEMORADIOTHERAPY: INSIGHTS FROM A RETROSPECTIVE STUDY Free
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.031, https://doi.org/10.1093/dote/doae057.031
Published: 02 September 2024
Journal Article
331. CASE-MIX ADJUSTMENT IN BETWEEN-HOSPITAL COMPARISONS ON CLINICAL OUTCOMES IN ESOPHAGEAL AND GASTRIC CANCER SURGERY: A NATIONWIDE POPULATION-BASED COHORT STUDY Free
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.093, https://doi.org/10.1093/dote/doae057.093
Published: 02 September 2024
Journal Article
785. MANAGEMENT OF ESOPHAGEAL CANCER WITH CONCURRENT CERVICAL NODE METASTASIS: A NATIONWIDE POPULATION-BASED COHORT STUDY Free
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.381, https://doi.org/10.1093/dote/doae057.381
Published: 02 September 2024
Journal Article
226. PHILOSOPHICAL CONSIDERATIONS IN SURGICAL INNOVATION Free
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.016, https://doi.org/10.1093/dote/doae057.016
Published: 02 September 2024
Journal Article
292. CHEMOTHERAPY AND CHEMORADIOTHERAPY FOR ADENOCARCINOMA OF THE OESOPHAGUS AND JUNCTION WITH OLIGOMETASTASES: RESULTS OF THE TNT-OES-1 TRIAL Free
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.063, https://doi.org/10.1093/dote/doae057.063
Published: 02 September 2024
Journal Article
517. INTERNATIONAL CONSENSUS AND CLINICAL CARE ALGORITHM FOR THE DIAGNOSIS AND TREATMENT OF ANASTOMOTIC LEAK AFTER ESOPHAGECTOMY Free
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.251, https://doi.org/10.1093/dote/doae057.251
Published: 02 September 2024
Journal Article
272. HOSPITAL VARIATION IN PALLIATIVE TREATMENT FOR ESOPHAGEAL AND GASTROESOPHAGEAL JUNCTION CANCER: A NATIONWIDE POPULATION-BASED STUDY IN THE NETHERLANDS Free
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.048, https://doi.org/10.1093/dote/doae057.048
Published: 02 September 2024
Journal Article
293. OUTCOMES AFTER SURGICAL TREATMENT OF OESOPHAGOGASTRIC CANCER WITH SYNCHRONOUS LIVER METASTASES: A MULTICENTRE RETROSPECTIVE COHORT STUDY Free
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.064, https://doi.org/10.1093/dote/doae057.064
Published: 02 September 2024
Journal Article
453. TREATMENT AND SURVIVAL OF PATIENTS WITH A POSITIVE RESECTION MARGIN AFTER NEOADJUVANT CHEMORADIOTHERAPY AND ESOPHAGECTOMY Free
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.240, https://doi.org/10.1093/dote/doad052.240
Published: 30 August 2023
Journal Article
220. INDUCTION CHEMOTHERAPY FOLLOWED BY RESTAGING AND SURGERY FOR ADVANCED ESOPHAGEAL CANCER Free
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.073, https://doi.org/10.1093/dote/doad052.073
Published: 30 August 2023
Journal Article
219. ASSOCIATION BETWEEN VIDEO-BASED SURGICAL PERFORMANCE AND PATIENT OUTCOMES IN MINIMALLY INVASIVE ESOPHAGECTOMY IN THE NETHERLANDS Free
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.072, https://doi.org/10.1093/dote/doad052.072
Published: 30 August 2023
Journal Article
221. INTERVAL METASTASES AFTER NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL CANCER: A MULTICENTER OBSERVATIONAL COHORT STUDY Free
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.074, https://doi.org/10.1093/dote/doad052.074
Published: 30 August 2023
Journal Article
283. 18F-FDG PET/MRI FOR RESTAGING ESOPHAGEAL CANCER AFTER NEOADJUVANT CHEMORADIOTHERAPY Free
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.116, https://doi.org/10.1093/dote/doad052.116
Published: 30 August 2023
Journal Article
266. EXTENSION OF FDG-PET-BASED RADIOMIC MODELS ON IDENTIFICATION OF PATIENTS WITH RESIDUAL ESOPHAGEAL CANCER AFTER NEOADJUVANT CHEMORADIOTHERAPY Free
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.266, https://doi.org/10.1093/dote/doac051.266
Published: 24 September 2022
Journal Article
333. THE EGIDIUS PROJECT: A NETWORK APPROACH TOWARDS EXCELLENT MULTIDISCIPLINARY QUALITY OF CARE FOR PATIENTS WITH ESOPHAGEAL AND GASTRIC CANCER Free
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.333, https://doi.org/10.1093/dote/doac051.333
Published: 24 September 2022
Journal Article
508. OUTCOME OF NEOADJUVANT CHEMORADIOTHERAPY PLUS SURGERY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA IN EAST ASIA VERSUS WESTERN EUROPE Free
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.508, https://doi.org/10.1093/dote/doac051.508
Published: 24 September 2022
Journal Article
796 OUTCOMES OF DELAYED SURGERY IN PATIENTS WITH RESIDUAL DISEASE AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR OESOPHAGEAL CANCER Free
Diseases of the Esophagus, Volume 34, Issue Supplement_1, September 2021, doab052.796, https://doi.org/10.1093/dote/doab052.796
Published: 17 September 2021
Journal Article
761 PATIENT PREFERENCES FOR ACTIVE SURVEILLANCE VERSUS STANDARD SURGERY AFTER NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL CANCER TREATMENT Free
Diseases of the Esophagus, Volume 34, Issue Supplement_1, September 2021, doab052.761, https://doi.org/10.1093/dote/doab052.761
Published: 17 September 2021
Journal Article
O18 TREATMENT OF ANASTOMOTIC LEAKAGE AFTER ESOPHAGECTOMY (TENTACLE STUDY) Get access
Diseases of the Esophagus, Volume 32, Issue Supplement_2, November 2019, doz092.18, https://doi.org/10.1093/dote/doz092.18
Published: 23 November 2019
